The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...

An asthma attack is a sudden worsening of asthma symptoms caused by inflammation and a narrowing of the airways. This can make breathing difficult and, in severe cases, be life-threatening. Asthma ...

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

Medically reviewed by Jurairat J. Molina, MD Key Takeaways Wheezing is a sign of an asthma attack and is caused by reduced ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

FDA approves GSK's Exdensur for severe eosinophilic asthma, backed by Phase 3 data showing up to 58% fewer asthma attacks ...

Younger women with asthma who use the progesterone-only contraceptive pill, often referred to as the mini pill, may face a heightened risk of severe asthma attacks, a new study suggests. Researchers ...

This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and ...

MADISON, Wis. (WMTV/Gray News) - A couple is suing Optum Rx and Walgreens for alleged negligence and unspecified damages after their son died of an asthma attack after he stopped taking his ...

Ten treatable traits in people with severe asthma can help predict asthma attacks, say authors of a study published online September 19 in Respirology. These traits are more prevalent in those with ...